Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Structure-Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic Stability.

Slack RD, Ku TC, Cao J, Giancola JB, Bonifazi A, Loland CJ, Gadiano A, Lam J, Rais R, Slusher BS, Coggiano M, Tanda G, Newman AH.

J Med Chem. 2019 Nov 14. doi: 10.1021/acs.jmedchem.9b01188. [Epub ahead of print]

PMID:
31661268
2.

Effect of systemically administered oxytocin on dose response for methylphenidate self-administration and mesolimbic dopamine levels.

Lee MR, Rohn MCH, Zanettini C, Coggiano MA, Leggio L, Tanda G.

Ann N Y Acad Sci. 2019 Nov;1455(1):173-184. doi: 10.1111/nyas.14101. Epub 2019 May 10.

PMID:
31074517
3.

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders.

Newman AH, Cao J, Keighron JD, Jordan CJ, Bi GH, Liang Y, Abramyan AM, Avelar AJ, Tschumi CW, Beckstead MJ, Shi L, Tanda G, Xi ZX.

Neuropsychopharmacology. 2019 Jul;44(8):1435-1444. doi: 10.1038/s41386-019-0366-z. Epub 2019 Mar 11.

PMID:
30858517
4.

A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids.

Yue K, Tanda G, Katz JL, Zanettini C.

Behav Pharmacol. 2019 Feb 7. doi: 10.1097/FBP.0000000000000474. [Epub ahead of print]

PMID:
30741729
5.

Effects of ( R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell.

Keighron JD, Quarterman JC, Cao J, DeMarco EM, Coggiano MA, Gleaves A, Slack RD, Zanettini C, Newman AH, Tanda G.

ACS Chem Neurosci. 2019 Apr 17;10(4):2012-2021. doi: 10.1021/acschemneuro.8b00340. Epub 2019 Jan 31.

PMID:
30645944
6.

Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors.

Zanettini C, Scaglione A, Keighron JD, Giancola JB, Lin SC, Newman AH, Tanda G.

Neuropharmacology. 2019 Dec 15;161:107446. doi: 10.1016/j.neuropharm.2018.11.034. Epub 2018 Nov 24.

PMID:
30481526
7.

Distinct effects of (R)-modafinil and its (R)- and (S)-fluoro-analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats.

Keighron JD, Giancola JB, Shaffer RJ, DeMarco EM, Coggiano MA, Slack RD, Newman AH, Tanda G.

Eur J Neurosci. 2019 Aug;50(3):2045-2053. doi: 10.1111/ejn.14256. Epub 2018 Dec 1.

PMID:
30402972
8.

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders.

Scherma M, Masia P, Deidda M, Fratta W, Tanda G, Fadda P.

Medicines (Basel). 2018 Oct 2;5(4). pii: E107. doi: 10.3390/medicines5040107. Review.

9.

Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas.

Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, Schwarcz R, Justinova Z.

Mol Neurobiol. 2019 May;56(5):3563-3575. doi: 10.1007/s12035-018-1319-y. Epub 2018 Aug 27.

PMID:
30151725
10.

Brain activity of anandamide: a rewarding bliss?

Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G.

Acta Pharmacol Sin. 2019 Mar;40(3):309-323. doi: 10.1038/s41401-018-0075-x. Epub 2018 Jul 26. Review.

PMID:
30050084
11.

Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.

Tunstall BJ, Ho CP, Cao J, Vendruscolo JCM, Schmeichel BE, Slack RD, Tanda G, Gadiano AJ, Rais R, Slusher BS, Koob GF, Newman AH, Vendruscolo LF.

Neuropharmacology. 2018 Mar 15;131:96-103. doi: 10.1016/j.neuropharm.2017.12.006. Epub 2017 Dec 5.

12.

The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.

Zhang HY, Bi GH, Yang HJ, He Y, Xue G, Cao J, Tanda G, Gardner EL, Newman AH, Xi ZX.

Neuropsychopharmacology. 2017 Aug;42(9):1871-1883. doi: 10.1038/npp.2017.41. Epub 2017 Mar 7.

13.

Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission.

Bonaventura J, Quiroz C, Cai NS, Rubinstein M, Tanda G, Ferré S.

Sci Adv. 2017 Jan 11;3(1):e1601631. doi: 10.1126/sciadv.1601631. eCollection 2017 Jan.

14.

Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening.

Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, Leak RK, Surratt CK.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:22-30. doi: 10.1016/j.pbb.2016.08.007. Epub 2016 Aug 26.

PMID:
27569602
15.

The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.

Mereu M, Chun LE, Prisinzano TE, Newman AH, Katz JL, Tanda G.

Eur J Neurosci. 2017 Jan;45(1):167-174. doi: 10.1111/ejn.13376. Epub 2016 Sep 11.

16.

Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids.

Tanda G, Mereu M, Hiranita T, Quarterman JC, Coggiano M, Katz JL.

Neuropsychopharmacology. 2016 Oct;41(11):2772-81. doi: 10.1038/npp.2016.91. Epub 2016 Jun 14.

17.

Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.

Tanda G.

Psychopharmacology (Berl). 2016 May;233(10):1845-66. doi: 10.1007/s00213-016-4244-7. Epub 2016 Mar 30. Review.

18.

Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Lee MR, Rohn MC, Tanda G, Leggio L.

CNS Drugs. 2016 Feb;30(2):109-23. doi: 10.1007/s40263-016-0313-z. Review.

19.

A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics.

Tanda G, Valentini V, De Luca MA, Perra V, Serra GP, Di Chiara G.

Psychopharmacology (Berl). 2015 Apr;232(8):1427-40. doi: 10.1007/s00213-014-3780-2. Epub 2014 Oct 28.

PMID:
25345736
20.

Effect of yohimbine on reinstatement of operant responding in rats is dependent on cue contingency but not food reward history.

Chen YW, Fiscella KA, Bacharach SZ, Tanda G, Shaham Y, Calu DJ.

Addict Biol. 2015 Jul;20(4):690-700. doi: 10.1111/adb.12164. Epub 2014 Jul 27.

Supplemental Content

Loading ...
Support Center